Biotech

All Articles

Takeda takes $140M loss on neglected epilepsy drug, promotes FDA manage

.Our team presently recognize that Takeda is actually hoping to locate a course to the FDA for epile...

VBI Injections declare personal bankruptcy, looks for possession purchase

.Immunology biotech VBI Vaccines is diverting hazardously near to the moment of truth, along with st...

Celldex anti-cKIT antitoxin decrease hives in another stage 2 research

.It's challenging to muscle in on a room as reasonable as immunology, but Celldex Therapeutics feels...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies and also a preclinical immune...

Ventyx's last resort for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's ailment medicine performed not help patients achieve remission in a per...

Cognition's period 2 radiate data blemish Alzheimer's possibility

.Knowledge Rehabs' period 2 sparkle test has actually taken a number of the radiance off the Alzheim...

BMS centers bispecific months after filing to work phase 3 trial

.Bristol Myers Squibb has had a whiplash change of heart on its BCMA bispecific T-cell engager, stop...

Charles Baum consumes Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squibb...

Asarina to shut after attempts to companion Tourette's drug fail

.After connecting to more than 200 providers to partner a Tourette syndrome therapy that revealed th...

Novartis pens $150M in advance bispecifics manage Dren Biography

.Novartis has had some rotten luck with bispecific antibodies in the past, yet evaluating due to the...